• Exchange: New York
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharmaceuticals

Forest Laboratories Inc

+ Add to Watchlist


89.5800 USD 0.7100 0.79%

As of 20:04:04 ET on 04/17/2014.

Snapshot for Forest Laboratories Inc (FRX)

Open: 89.8300 Day's Range: 89.0000 - 90.7400 Volume: 1,095,921
Previous Close: 90.2900 52wk Range: 35.5000 - 100.8800 1-Yr Rtn: +149.46%

Stock Chart for FRX

No chart data available.
  • FRX:US 89.5800
  • 1D
  • 1M
  • 1Y
Interactive FRX Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for FRX

Current P/E Ratio (ttm) 113.6521
Estimated P/E(03/2014) 67.2523
Relative P/E vs. SPX 6.6088
Earnings Per Share (USD) (ttm) 0.7882
Est. EPS (USD) (03/2014) 1.3320
Est. PEG Ratio 1.5496
Market Cap (M USD) 24,272.68
Shares Outstanding (M) 270.96
30 Day Average Volume 2,952,999
Price/Book (mrq) 4.0349
Price/Sale (ttm) 7.1243
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 04/29/2014
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for FRX

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for FRX

Forest Laboratories, Inc. develops, manufactures and sells branded forms of ethical drug products, most of which requires a physician's prescription. The Company also focuses on the development and introduction of new products, including products developed in collaboration with licensing partners.

Brenton L Saunders "Brent"President/CEOFrancis I Perier Jr "Frank"Exec VP/CFO
Marco TagliettiExec VP:Drug Dev/Chief Mediacl OfficerElaine HochbergExec VP:Government Affairs
More Company Profile & Key Executives for FRX

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Links
sec ||= nil